Hip Fracture Surgery in Elderly Patients
- Registration Number
- NCT01199276
- Lead Sponsor
- Air Liquide Santé International
- Brief Summary
The objective of this study is to evaluate the incidence of Post-Operative Delirium (POD), diagnosed with the Confusion Assessment Method (CAM), in elderly patients undergoing hip fracture surgery under general anaesthesia with xenon or sevoflurane, for a period of four days post-surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 256
- Elderly patient (≥ 75 years)
- Patient with planned hip fracture surgery within 48 hours after the hip fracture
- Patient willing and able to complete the requirements of this study including the signature of the written informed consent
- Patient suffering from multiple fractures, pelvic fractures proximal, pathological fractures, femur fractures (i.e., fractures of the middle or distal femur)
- Disabling neuropsychiatric disorders (severe dementia, Alzheimer's disease, schizophrenia, depression)
- Brain trauma within 12 months prior to selection, history of stroke with residuals
- Patient suffering from delirium (CAM diagnosis) at selection
- Patient who cannot complete the pre-operative mental tests (CAM and/or MMSE) of this clinical trial
- Patient with Mini-Mental State Examination (MMSE) score < 24 at selection
- Patient known to susceptible to malignant hyperthermia
- Patient with elevated intra-cranial pressure
- Patient with a risk of high oxygen demand
- Patient with recent or ongoing myocardial infarction / damage
- Patient with severe cardiac failure, or patient with severe impaired left ventricular systolic function
- Patient with known severe lung and/or airway disease, or severe chronic respiratory insufficiency, or a sustained homecare oxygen therapy
- Contra-indication (serious illness or medical conditions) for general anaesthesia
- Known allergy or hypersensitivity to any drugs administered during this clinical trial
- Previous participation in this clinical trial
- Participation in another clinical trial within 4 weeks prior to selection
- History of alcohol or drug abuse or psychiatric disorders which would impair the understanding of the necessary information or render medically or legally unable to give written informed consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Xenon Xenon 60%(1MAC)in oxygen (FiO2 = 0.35-0.45) Sevoflurane Sevoflurane 1.1-1.4% (1 MAC) in oxygen (FiO2 = 0.35-0.45) and medical air
- Primary Outcome Measures
Name Time Method Post Operative Delirium diagnosed with the Confusion Assessment Method within four days post-surgery Four days
- Secondary Outcome Measures
Name Time Method Recovery Parameters fifteen minutes Post Operative Delirium diagnosed with the Confusion Assessment Method from day 5 post surgery to discharge from hospital About 7 days Sequential Organ Failure Assessment from day 1 to day 4 post-surgery four days economic parameters up to thirty days Safety Parameters Up to thirty days Serious Adverse Events, Adverse Events, laboratory parameters
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (13)
UZ Leuven
🇧🇪Leuven, Belgium
Centre Hospitalier Universitaire de Grenoble
🇫🇷La Tronche, France
Centre Hospitalier Régional Universitaire de Montpellier
🇫🇷Montpellier, France
Groupe Hospitalier COCHIN
🇫🇷Paris cedex 14, France
Groupe Hospitalier La Pitié-Salpêtriere
🇫🇷Paris, France
CHU Pontchaillou - Université de Rennes 1
🇫🇷Rennes, France
Centre Hospitalier Universitaire de Toulouse
🇫🇷Toulouse, France
University Hospital Aachen
🇩🇪Aachen, Germany
. Klinik für Anästhesiologie - Universitätsklinikum Düsseldorf
🇩🇪Düsseldorf, Germany
Klinikum Mutterhaus Der Borromaerinnen
🇩🇪Trier, Germany
Scroll for more (3 remaining)UZ Leuven🇧🇪Leuven, Belgium